Member Info for Saxondale

Why is it that any time I see a Bitcoin article written more than 1 hour ago , its not worth reading as its out of date ?

Mine turned up today - very impressed .
I agree , Amazon advert is rubbish , but hopefully that is being addressed , although a 13yr old could have done it better in 5 minutes . It doesn't take much to add a few proper pictures and big up the copper nanoparticle anti viral aspect .
I mean if you have a USP , use it !!
Anyway - pleased to see a physical mask in my possession - trips to supermarkets etc will be much safer than using the rubbish fabric thing I have been using .

So - good to see them getting the mask available to be purchased - but now - get them into the hands of influencers / politicians / NHS affiliated companies , and lets get the word out far and wide .

I bought mine from Virionmask.co.uk .
Thats because I frequent this BB and found a link

I 100% bet that my missus would never be able to buy one if I told her to google antiviral copper mask . So there we have the problem . RMS need to spend some money on getting it known .

Stimulus cheques going straight into Crypto ?

Very watchable interview - good question and answers - nothing cringeable - really slick .
USA certainly a major focus - be it getting more mining on US Soil , or opening up investment opportunities to US via Nasdaq .
Really positive.
I get the feeling that their team , along with Pluto are working on projects that ordinary people like me would not have the foggiest idea what they were - but somehow , in the future , they will be very profitable .
I'll just own the shares and let them get on with it .

Just ordered my pack of 10 - £13.99
Easy payment - order confirmed .
Thought I'd better get in before the rush !

I'm in at 2p again today - after selling out twice during the Fawlty Towers RNS period .
Things are looking up - no more Basil Fawlty plot lines now please .
If the line manager gets diarrhea , we don't need an RNS about it .
Lets just have real news . Looks like ITV may just light the fuse tonight !!
Maybe that's why he put a clean coat on ?

They'd have to RNS before conference , but personally don't think they will change presentation from the last one this week .
Interviews and Conferences just allow you to pick up on the speakers sentiment , although Markku ain't no Megan Markle . The last time he managed a smile we all thought it was the second coming .

A more important date in the diary may be the 25th March - Financial statement and Annual Report .

Hopefully that will put more meat on the bone with these Phase 2 results - only 2 weeks away , but surely they have to give us some news surely .

Please let this be the real thing , I've got much i want to do with my EUA winnings !!

Just a quick question , was there a reason why back in 2017 they didn't list under AIM to start with ?
I hold plenty of AIM stocks , so not bothered , and I think I sort of understand why they are doing it , just curious .

Another top notch set of results - thanks for the GGP live last night too .
Increasing grades of Copper too .
This discovery just keeps on giving .

Markku isn't a salesman , he's a scientist , and a Finnish one at that - so he is dry and scientific , but also very passionate - this is his lifes work pretty much , and he has always let the science and the data come before the sales pitch . He knows that the science will bring huge rewards so long as they steer it correctly , and make sure that the research is geared towards the right goals .
So far , they have garnered enough funding to get them to a 10 cohort P2 cancer trial , and a US sponsored P3 trial , all whilst maintaining 100% ownership , and without diluting the shareholders to oblivion .
Placings may occur in the future , I had one last night with ARGO for £26 million , and they have cash coming out of their ears , but if it adds long term value to the share , then its justifiable . Faron are savvy enough to see an opportunity if a further placing will get them to a better place - so its up to them , you have to have faith in their management .
Whether we will see some deals , tie ups with other companies on certain cancer trials , I really don't know . I think we probably will in Q2 . They have been analysing the P2 data , and need to prove it up to satisfy potential partners . Markku has said this himself . So once that data is published , we may start getting into the money making dept .
The beauty of this company is that they have 10 cohorts - 10 different cancer types . Plus the soluble clever1 suppression , and the fact that it has the potential to be combined with other therapies . Plus Traumakine - which looks to be gaining traction as a multi purpose trauma therapy , as well as being a prime treatment for ARDS , and a general antiviral therapy .
Heamatokine could also be a dark horse , as they are actively looking to partner up with regenerative medicine players in the space .
Hollman Labs are making new discoveries about Clever 1 , and I expect Faron are also making new discoveries from all this P2 data they have coming in .

Markku has plenty of skin in the game , as do the directors and BOD . It's in his interest to get the SP high .

The data will get them and us there . For a small Finnish Biotech , they are getting very close to establishing themselves as a major player . They have established great relationships with top notch institutions , particularly in the States . Manufacturing , Patents , etc , its all in place .

We've been given the jam tomorrow story a few times , and I suppose we are all free to sell up and move on , but Faron have always passed the smell test for me , all their actions have been totally justifiable , and I believe they will deliver .

I certainly hope so . Mind you , the POG ( and Silver ) will rise when the powers that be are ready for it to . All we can do at the moment is position ourselves with the right stocks and wait for the ticking timebomb to blow . I'm covering myself with crypto in the form of a bitcoin miner too , so I'm backing every horse in the race except the $ . I just hope I get the chance to spend all these $ before they aren't worth the paper they're written on .

Link now up to watch the conference today

https://journey.ct.events/view/7f8b2fe4-0911-49b8-897d-9c1a350040ec

Another upbeat and confident presentation .

No RNS worthy updates - although I did pick up the following bits which relate to recent events :

* 5 of the 10 cohorts of Bexmarilimab have already shown enough positive data to qualify for Phase 3
*They are having to take their time with analysis on phase 2 , as they want to get the dosing and frequency sorted out , since the soluble Clever 1 discovery - hence perhaps why it has lagged over into Q1-2 this year .
*In the near term , there will be some data released from Phase 2 which will be very much worth reading .
*Shareholder value was mentioned - but only in as much as now is when it will start to kick in - but also that it will be for the next few years - so no 3 month window this time .
*Data on Phase 2 cohorts will be release Q2
*Regarding Traumakine - Hibiscus is pretty much ready to go - still penciled in to be initiated Q1
*REMAP-CAP Interim data expected Q2
* A Traumakine Scientific Advisory Board to be created in Q3 - no details on what that means exactly
*Interim Data on Hibiscus Q3
* Mentioned again that he believes I/V is better than Inhaled at getting the IFN Beta1 to the place it needs to be , and that steroids can be used afterwards .
* Interesting that he mentioned the use in Trauma and major organ failure cases , and also Kidneys being a major beneficiary of Traumakine too - as they too are a filtering organ like the lungs with lots of capillaries .
* mentioned the Fast Track Status / Orphan Status etc again - and how everything is ready to go once they get the green light.
* Brief mention of Heamatokine too , and how that will start progressing .

All in all - a quick and fact packed presentation - he obviously only had 20 minutes to cram it all in .

All in all , he did a good job of laying out a roadmap for the next 2-3 years of building on the expansion of the 3 therapies -

So - back to waiting for some NEW news lol

Haven't posted much here for a while , as GGP is just quietly getting on with business . A reminder of just what we have , and how valuable it will be . Looking forward to 14/14 on Weds . Its almost fortunate that we don't have any gold/copper to sell yet , as when we do have it out it will be worth a fair bit more that's for sure .

Markku presenting at Carnegie Nordic Virtual Healthcare Seminar 2021 on Friday 12th March too .

Dr Markku Jalkanen, CEO is presenting the company on Friday March 12 at 14:15 CET. Event registration is managed by Carnegie

Conference is Tues . Yes , it's not timed to suit Faron , just a big investor conference .
Not sure how far this current funding will take them , but lets assume its through to Q4 2021 .

Looking back at their presentation on 24th Sept 2020 - they had a slide for upcoming milestones .

2020 Q4 - Topline data from first expansion cohorts in MATINS (so presumably they have some , but are still analysing it , possibly delayed due to the next milestone below)

2021 Q1 - Final dosage and dose frequency decision ( this has been going on we know , particularly with the soluble clever 1 discovery causing them to want to increase frequency of dosing )

So far all we have got is a glimpse of what these P2 cohorts are throwing up .
*Positive reaction with all cohorts
* Soluble clever 1 suppression noted , although with long dosing frequency , the effects are temporary , so FDA happy for them to increase frequency , as tolerability levels are well within their limits .
*Expansion into further cohorts , including lung and heamatological areas .

So all extremely positive , even ' remarkable ' .

I'm expecting Markku to run an updated presentation with all these positive updates .

He has some breathing space financially , so why not get out there and tout for more partners , and show off what Faron are onto .

Would be nice to get the big one though .

To any new investors - this is a good read

https://www.faron.com/sites/default/files/H1-2020%20Faron%20presentation%20final.pdf

Just topped up a couple of grand here . Looking forward to more results , especially the 8 zone .
Wish i'd done it the other day sub £1
Oh well its only 7p , when it comes good that won't make much difference .

Still kicking myself I sold these at 50p last year .

With POG possibly hitting bottom levels now , looking for a much better outlook this year .

Can anyone explain what sales qty of masks would be needed to justify say a 10p SP ?

I'm wanting to get back in , but just not sure of how many of these things need to get sold / licensed in some sort of deal ?

Or is the SP hope based purely on hope that the NHS or someone will pick up on it and run ?

The last RNS I read said they only had materials for a few months for the machine in Nottingham ?

Not a deramp - just want to see where this is coming from before I get back in potentially .

I think it may well be very relevant Pebble .
The suppression of Clever 1 , and soluble clever 1 is at the heart of Bexmarilimab ( there , I wrote it for the first time without having to check spelling ! )
Hollmen lab are obviously running ongoing research into what Clever 1 does , and what it prevents .

The recent soluble Clever 1 discovery by Faron , shows that they seem to be able to suppress Clever 1 ( and soluble Clever1 , ie the sort that runs around the body , and into the hundreds of lymph nodes potentially spreading cancer from the solid tumour) , so the more they know about Clever 1 , the more important a drug that can suppress it will become .

Yep , Nasdaq was my immediate thought . Cheeky little question there , didn't need an answer , she knew she wouldn't get one , but the coy smiles all round , like you say doesn't take a genius to read a little between the lines as to what they small talk was about before the interview began .